Allianz Asset Management Gmb H Puma Biotechnology, Inc. Transaction History

Allianz Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$59.7 - $99.25 $262,202 - $435,906	-4,392 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$93.85 - $132.45 $98,448 - $138,940	1,049 Added 31.38%	4,392 $434,000
Q3 2017 Nov 13, 2017	SELL	$72.0 - $119.75 $32,832 - $54,606	-456 Reduced 12.0%	3,343 $400,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,799	3,799 $330,000

107

32.2M

43.4K

3.7K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $130M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.